Biological Features

PD is associated with a range of biological features observable via histological and biochemical examination of tissue, brain imaging, and in vivo electrophysiological recordings.

Micrograph of brain cells containing a Lewy bodyImage by Kondi Wong, Armed Forces Institute of PathologyMicrograph of brain cells containing a Lewy bodyImage by Kondi Wong, Armed Forces Institute of PathologyAt present, conclusive diagnosis of PD requires post mortem examination of neural tissue that identifies characteristic histopathological features, including Lewy bodies. Neuron loss and gliosis (spongiosis) is observed, as well as neuronal lesions. These lesions can include a number of proteins and protein structures, though the relationship between these structures and pathology of the disease remains unclear. Some proteins associated with PD and related neurodegenerative diseases include:

  • Alpha-synuclein, a major constituent of Lewy bodies, which are defining features of PD
  • Tau, which forms neurofibrillary tangles and Pick bodies
  • Ubiquitin, also found in Motor Neuron Disease Inclusions (MND-I)

Glial lesions are also observed in PD, and can be composed of tau, found in coiled bodies and tufted astrocytes or astrocytic plaques, and/or alpha-synuclein, observed in glial cytoplasmic inclusions.

 

 

16 Mar 2010
The relationship of Parkinson disease with dementia (PDD) and Dementia with Lewy bodies (DLB) is obviously an important conceptual issue for studies involving post-mortem tissues (DLB/PDD working ... 
12 Mar 2010
First, you have to realize that the clinical diagnosis of DLB is only about 50% accurate overall. This may be better in situations where the clinical syndrome of DLB is all there in spades but even ... 
10 Mar 2010
There is still an on-going debate concerning whether Parkinson disease with dementia (PDD) and dementia with Lewy bodies  (DLB) are distinct entities. Clinically, both conditions can be ... 
Responses: 2
24 Mar 2009
AVilla Mondragone, Rome, Italy Contact: Antonio Pisani, MD, University of Rome Tor Vergata, Rome, Italy; TEL: +39-0672596010; FAX: +39-0672596006; E-mail: pisani@uniroma2.it Web site: dystonia.uniroma2.it/   ... 
Published today in the Journal of Neuroscience, Dr. Carlos Paladini and colleagues get to the bottom of burst firing activity in dopaminergic neurons of the substantia nigra. Together with recent ... 
15 Dec 2009
Responses: 4
The Alzheimer’s Drug Discovery Foundation (ADDF) and The Lewy Body Dementia Association (LBDA) are issuing a Request for Proposals for the 2010 ADDF/LBDA Lewy Body Dementia Biomarker Research ... 
08 Sep 2009
10 Jun 2009
This group aims to promote interactions, collaborations and the exchange of ideas of those members interested in developing or characterizing genetic disease models, particularly mouse models. ...